Am J Health-Syst Pharm
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
American Journal of Health-System Pharmacy, Vol 60, Issue 6, 593-598
Copyright © 2003 by American Society of Health-System Pharmacists

Articles

ASHP therapeutic position statement on the use of statins in the prevention of atherosclerotic vascular disease in adults


Elevated blood cholesterol levels contribute significantly to ASVD and are often undertreated or not treated at all. Evaluation and management of lipid disorders should be guided by current NCEP guidelines. For patients with elevated cholesterol levels after appropriate therapeutic lifestyle changes, statins are a safe and effective means of reducing cardiovascular events. Because of their proven safety and effectiveness, ASHP supports the use of statins as first-line therapy for the primary and secondary prevention of atherosclerotic events.
 



This article has been cited by other articles:


Home page
 Am J Health Syst PharmHome page
ASHP Statement on the Over-the-Counter Availability of Statins
Am. J. Health Syst. Pharm., November 15, 2005; 62(22): 2420 - 2422.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Society of Health-System Pharmacists.